Literature DB >> 11746940

Improved target volume characterization in stereotactic treatment planning of brain lesions by using high-resolution BOLD MR-venography.

L R Schad1.   

Abstract

In this methodological paper I report the stereotactic correlation of different magnetic resonance imaging (MRI) techniques [MR angiography (MRA), MRI, blood bolus tagging (STAR), functional MRI, and high-resolution BOLD venography (HRBV)] in patients with cerebral arterio-venous malformations (AVM) and brain tumors. The patient's head was fixed in a stereotactic localization system which is usable in both MR-systems and linear accelerator installations. Using phantom measurements global geometric MR image distortions can be 'corrected' (reducing displacements to the size of a pixel) by calculations based on modeling the distortion as a fourth-order two-dimensional polynomial. Further object-induced local distortions can be corrected by additionally measured field maps. Using this method multimodality matching could be performed automatically as long as all images are acquired in the same examination and the patient is sufficiently immobilized to allow precise definition of the target volume. Information about the hemodynamics of the AVM was provided by a dynamic MRA with the STAR technique, leading to an improved definition of the size of the nidus, the origin of the feeding arteries, whereas HRBV imaging yielded detailed and improved information about the venous pattern and drainage. In addition, functional MRI was performed in patients with lesions close to the primary motor cortex area, leading to an improved definition of structures at risk for the high-dose application in radiosurgery. In patients with brain tumors the potential of HRBV to probe tumor angiogenesis and its use in intensity-modulated treatment planning is still hampered by the open question of how to translate a BOLD signal pattern measured in the tumor to a dose distribution, which should be addressed in future studies. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746940     DOI: 10.1002/nbm.714

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  10 in total

1.  Susceptibility-weighted imaging in patients with pyogenic brain abscesses at 1.5T: characteristics of the abscess capsule.

Authors:  P H Lai; H C Chang; T C Chuang; H W Chung; J Y Li; M J Weng; J H Fu; P C Wang; S C Li; H B Pan
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-26       Impact factor: 3.825

2.  High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings.

Authors:  K Pinker; I M Noebauer-Huhmann; I Stavrou; R Hoeftberger; P Szomolanyi; G Karanikas; M Weber; A Stadlbauer; E Knosp; K Friedrich; S Trattnig
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

3.  Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis.

Authors:  Jan Klohs; Andreas Deistung; Ferdinand Schweser; Joanes Grandjean; Marco Dominietto; Conny Waschkies; Roger M Nitsch; Irene Knuesel; Jürgen R Reichenbach; Markus Rudin
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-17       Impact factor: 6.200

Review 4.  Functional magnetic resonance imaging in pediatrics.

Authors:  M Wilke; S K Holland; J S Myseros; V J Schmithorst; W S Ball
Journal:  Neuropediatrics       Date:  2003-06       Impact factor: 1.947

Review 5.  Susceptibility-weighted MR imaging: a review of clinical applications in children.

Authors:  K A Tong; S Ashwal; A Obenaus; J P Nickerson; D Kido; E M Haacke
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

Review 6.  Susceptibility-weighted imaging: technical aspects and clinical applications, part 1.

Authors:  E M Haacke; S Mittal; Z Wu; J Neelavalli; Y-C N Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2008-11-27       Impact factor: 3.825

7.  [Use of contrast agent in high-field MRI (3 T)].

Authors:  S Trattnig; A Ba-Ssalamah; I M Nöbauer-Huhmann; M Barth; K Pinker; V Mlynarik
Journal:  Radiologe       Date:  2004-01       Impact factor: 0.635

Review 8.  Susceptibility-weighted imaging: clinical angiographic applications.

Authors:  Samuel R S Barnes; E Mark Haacke
Journal:  Magn Reson Imaging Clin N Am       Date:  2009-02       Impact factor: 2.266

9.  Windows on the human body--in vivo high-field magnetic resonance research and applications in medicine and psychology.

Authors:  Ewald Moser; Martin Meyerspeer; Florian Ph S Fischmeister; Günther Grabner; Herbert Bauer; Siegfried Trattnig
Journal:  Sensors (Basel)       Date:  2010-06-08       Impact factor: 3.576

10.  Spatiotemporal dynamics of the functional architecture for gain fields in inferior parietal lobule of behaving monkey.

Authors:  Ralph M Siegel; Jeng-Ren Duann; Tzyy-Ping Jung; Terrence Sejnowski
Journal:  Cereb Cortex       Date:  2006-04-07       Impact factor: 5.357

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.